经皮椎体球囊扩张成形术治疗骨质疏松性椎体压缩性骨折临床疗效及对椎体高度丢失的影响

Clinical Efficacy of Percutaneous Vertebroplasty in the Treatment of Osteoporotic Vertebral Compression Fractures and its Effect on Vertebral Height Loss

目的研究经皮椎体球囊扩张成形术(PKP)治疗骨质疏松性椎体压缩性骨折(OVCF)的临床疗效及对椎体高度丢失的影响。方法选取2018年1月-2022年12月贵溪市中医院骨科收治的78例OVCF病例,按照随机数字表法分为对照组(39例)与观察组(39例)。对照组行保守治疗,观察组给予PKP治疗,比较两组临床疗效、视觉模拟疼痛评分(VAS)评分、Oswestry功能障碍指数(ODI)评分、椎体变化(椎体前缘高度、后凸cobb角)、并发症。结果观察组治疗总有效率高于对照组(P<0.05)。两组治疗后VAS、ODI评分均小于治疗前,且观察组VAS、ODI评分小于对照组(P<0.05)。对照组治疗前后椎体前缘高度比较,差异无统计学意义(P>0.05),治疗后后凸cobb角小于治疗前(P<0.05);观察组椎体前缘高度大于治疗前,后凸cobb角小于治疗前(P<0.05)。两组治疗并发症发生率比较,差异无统计学意义(P>0.05)。结论PKP治疗OVCF疗效确切,可恢复患者椎体高度,矫正其后凸畸形,促进疼痛及功能障碍缓解,安全性高。

Objective To study the clinical efficacy of percutaneous vertebroplasty(PKP)in the treatment of osteoporotic vertebral compression fractures(OVCF)and its effect on vertebral height loss.Methods The observation group had the higher total treatment efficiency rate than that in the control group(P<0.05).Both groups had lower VAS and ODI scores after treatment than those in before,and the observation group had lower VAS and ODI scores than those in the control group(P<0.05).The height of the anterior edge of the vertebral body before and after treatment in the control group were no significant difference(P>0.05),but the kyphosis cobb angle after treatment was smaller than that before treatment in the control group(P<0.05).The height of the anterior edge of the vertebral body in the observation group was higher than that before treatment,and the kyphosis cobb angle was smaller than that before treatment(P<0.05).The incidence of treatment complications between the two groups were no significant difference(P>0.05).Conclusion PKP is effective in the treatment of OVCF,which can restore the vertebral height,correct the kyphosis deformity,promote the relief of pain and dysfunction,and has high safety.